ReneSola Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReneSola in the last twelve months. There are currently 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ReneSola stock.
View analyst ratings for ReneSola or view top-rated stocks.

3 brokerages have issued 12-month price targets for ReneSola's stock. Their SOL stock forecasts range from $10.00 to $12.50. On average, they expect ReneSola's stock price to reach $11.50 in the next twelve months. This suggests a possible upside of 139.1% from the stock's current price.
View analysts' price targets for ReneSola or view top-rated stocks among Wall Street analysts.

ReneSola's stock was trading at $5.96 at the start of the year. Since then, SOL shares have decreased by 19.3% and is now trading at $4.81.
View the best growth stocks for 2022 here.

ReneSola is scheduled to release its next quarterly earnings announcement on Monday, August 29th 2022.
View our earnings forecast for ReneSola.

ReneSola Ltd (NYSE:SOL) released its earnings results on Tuesday, June, 7th. The semiconductor company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.03. ReneSola had a trailing twelve-month return on equity of 1.67% and a net margin of 7.29%. During the same quarter in the previous year, the firm posted $0.05 earnings per share.
View ReneSola's earnings history.

ReneSola's stock reverse split on Friday, February 10th 2017. The 1-5 reverse split was announced on Monday, January 30th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 9th 2017. An investor that had 100 shares of ReneSola stock prior to the reverse split would have 20 shares after the split.

ReneSola declared that its Board of Directors has initiated a stock repurchase program on Monday, December 6th 2021, which permits the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 12.3% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

ReneSola issued an update on its FY 2022 earnings guidance on Tuesday, June, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $100.00 million-$120.00 million, compared to the consensus revenue estimate of $111.13 million.

34 employees have rated ReneSola CEO Xian Shou Li on Glassdoor.com. Xian Shou Li has an approval rating of 28% among ReneSola's employees. This puts Xian Shou Li in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to ReneSola include Photronics (PLAB), ChipMOS TECHNOLOGIES (IMOS), SMART Global (SGH), indie Semiconductor (INDI), Alpha and Omega Semiconductor (AOSL), NeoPhotonics (NPTN), Netlist (NLST), Netlist (NLST), Ichor (ICHR), Magnachip Semiconductor (MX), Canaan (CAN), Navitas Semiconductor (NVTS), Maxeon Solar Technologies (MAXN), nLIGHT (LASR) and FTC Solar (FTCI).
View all of SOL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ReneSola investors own include Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Nokia Oyj (NOK), FuelCell Energy (FCEL), Advanced Micro Devices (AMD), SunPower (SPWR), VBI Vaccines (VBIV), First Solar (FSLR), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

ReneSola trades on the New York Stock Exchange (NYSE) under the ticker symbol "SOL."

ReneSola's stock is owned by many different institutional and retail investors. Top institutional shareholders include Invesco Ltd. (9.53%), State Street Corp (4.25%), BlackRock Inc. (0.56%), First Trust Advisors LP (0.51%), JPMorgan Chase & Co. (0.27%) and Mitsubishi UFJ Kokusai Asset Management Co. Ltd. (0.21%). Company insiders that own ReneSola stock include Barlow Todd and Shah Capital Management.
View institutional ownership trends for ReneSola.

SOL stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., State Street Corp, JPMorgan Chase & Co., First Trust Advisors LP, Jane Street Group LLC, Harel Insurance Investments & Financial Services Ltd., BlackRock Inc., and Citigroup Inc..
View insider buying and selling activity for ReneSola or view top insider-selling stocks.

SOL stock was bought by a variety of institutional investors in the last quarter, including Group One Trading L.P., Krane Funds Advisors LLC, PEAK6 Investments LLC, Goldman Sachs Group Inc., Ergoteles LLC, Dynamic Technology Lab Private Ltd, Atria Wealth Solutions Inc., and Veriti Management LLC.
View insider buying and selling activity for ReneSola or or view top insider-buying stocks.

Shares of SOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SOL stock can currently be purchased for approximately $4.81.

ReneSola (NYSE:SOL) has a market capitalization of $322.92 million and generates $79.66 million in revenue each year. The semiconductor company earns $6.86 million in net income (profit) each year or $0.06 on an earnings per share basis.

ReneSola employs 147 workers across the globe.

ReneSola was founded in 2005.

ReneSola's mailing address is 3RD FLOOR 850 CANAL ST, STAMFORD CT, 06902. The official website for ReneSola is www.renesolapower.com. The semiconductor company can be reached via phone at (347) 577-9055, via email at [email protected], or via fax at 347-577-9985.